CNTA – centessa pharmaceuticals plc - american depositary shares (US:NASDAQ)

News

Centessa Pharmaceuticals (CNTA) had its "equal weight" rating reaffirmed by Wells Fargo & Company. They now have a $42.00 price target on the stock, up from $35.00.
Centessa Pharmaceuticals (CNTA) was downgraded by Truist Financial Corporation from "buy" to "hold". They now have a $38.00 price target on the stock.
Shareholder Alert: The Ademi Firm investigates whether Centessa Pharmaceuticals plc is obtaining a Fair Price for Public Shareholders
Centessa Pharmaceuticals (CNTA) had its "neutral" rating reaffirmed by Guggenheim.
Centessa Pharmaceuticals (CNTA) was downgraded by B. Riley Financial, Inc. from "strong-buy" to "hold".
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com